midazolam has been researched along with lenvatinib in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Aluri, J; Dutcus, CE; He, C; Rance, C; Ren, M; Shumaker, R | 1 |
1 trial(s) available for midazolam and lenvatinib
Article | Year |
---|---|
An Open-Label Phase 1 Study to Determine the Effect of Lenvatinib on the Pharmacokinetics of Midazolam, a CYP3A4 Substrate, in Patients with Advanced Solid Tumors.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Area Under Curve; Cytochrome P-450 CYP3A; Drug Interactions; Female; Half-Life; Humans; Male; Midazolam; Middle Aged; Neoplasms; Phenylurea Compounds; Quinolines | 2020 |